Predictive Mutation Signature of Immunotherapy Benefits in NSCLC Based on Machine Learning Algorithms
Frontiers in Immunology（2022）
Key words
non-small cell lung cancer (NSCLC),machine learning (ML),immunotherapy,gene,tumor mutational burden (TMB)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined